Plus Therapeutics (PSTV) Stock Highlights

1 | -6.54%

2024-12-19 07:04:32

Plus Therapeutics Inc is a clinical-stage pharmaceutical company. The company focused on the discovery, development, and delivery of complex and innovative treatments for patients battling cancer and rare diseases. Its product pipeline includes Patented RNL and Patented DocePLUS.

Statistics

Range Today

0.98 1.1

Volume Today 79.4K

Range 1 Year

1.03 2.67

Volume 1 Year 16.08M

Range 3 Year

0.97 32.4

Volume 3 Year 101.21M

Range 10 Year

0.97 165375

Volume 10 Year 129.75M

Highlights

Market Capitalization 8.02M (micro)

Floating Shares 5.75M

Current Price 1

Price To Earnings -0.48

Price To Revenue 0.41

Earnings Per Share -2.79

Payout Ratio 0%

Performance

Latest -6.54%

1 Month -17.36%

3 Months -37.5%

6 Months -50.74%

1 Year -47.92%

3 Years -94.1%

5 Years -97%

10 Years -100%

Benchmarks

Market Capitalization

346 / 368

Gross Profits

159 / 278

Total Revenue

210 / 300

Total Rank

345 / 368

Free Cashflow

81 / 352

Performance 5 years

329 / 368

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.